ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Baillie Gifford International Alpha ETF
25.00
0.0000
成交量：
12
成交額：
300.60
市值：
3.25億
市盈率：
- -
高：
25.00
開：
25.00
低：
25.00
收：
25.00
52周最高：
25.97
52周最低：
23.97
股本：
1,301.20萬
流通股本：
1,301.20萬
量比：
0.00
換手率：
0.00%
股息：
- -
股息率：
- -
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
諾和諾德攜手Anthropic，利用AI加速藥物研發
TradingKey中文
·
2小時前
美股異動丨諾和諾德盤前升逾1% 將與Anthropic合作推進藥物研發
格隆汇
·
3小時前
諾和諾德與Anthropic將合作使用Claude推進藥物研發
第一财经
·
3小時前
諾和諾德與Anthropic將合作推進藥物研發，諾和諾德將使用Claude輔助研發工作流程。
格隆汇
·
3小時前
諾和諾德(NVO.US)盤前拉升升逾1%，公司將與Anthropic合作推進藥物研發。
智通财经
·
3小時前
諾和諾德將使用Claude Science開展研發工作流。
智通财经
·
3小時前
諾和諾德與Anthropic開展合作，藉助Claude推進藥物研發。
智通财经
·
3小時前
市場消息：諾和諾德(NVO.US)與Anthropic將合作推進藥物研發。
智通财经
·
3小時前
諾和諾德(NVO.US)首席執行官：諾和諾德需要擴大其業務範圍以應對未來挑戰。
智通财经
·
昨天
美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄
智通财经
·
昨天
美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄
智通财经
·
昨天
台積電德國廠封頂，廠房主體工程完成
智通财经
·
昨天
時序進入第三季下旬，台積電3nm、2nm先進製程與CoWoS先進封裝產能持續供不應求。供應鏈人士透露，英偉達、蘋果等持續
智通财经
·
昨天
美股開盤 | 三大股指集體低開！半導體板塊普跌，邁威爾科技、ARM跌超7%
老虎资讯综合
·
09/14
諾和諾德公司開啓股份回購計劃。
智通财经
·
09/14
諾和諾德(NVO.US)更名「Novo」煥新出發 多線突圍能否驅散股價陰霾？
智通财经
·
09/14
諾和諾德(NVO.US)更名「Novo」煥新出發 多線突圍能否驅散股價陰霾？
智通财经
·
09/14
諾和諾德更名為「諾和（Novo）」，全力爭奪減肥藥市場份額
环球市场播报
·
09/14
諾和諾德(NVO.US)：公司將品牌名稱更新為「Novo」，並調整企業文化。此舉是為了幫助公司重新奪回減肥藥市場份額。
智通财经
·
09/14
歐洲科技股普遍走低 阿斯麥下跌4.1%
东方财富Choice...
·
09/14
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/BGIA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BGIA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGIA\",,,,,undefined,":{"symbol":"BGIA","market":"US","secType":"STK","nameCN":"Baillie Gifford International Alpha ETF","latestPrice":24.9961,"timestamp":1789568945597,"preClose":24.9961,"halted":0,"volume":12,"delay":0,"changeRate":0,"floatShares":13012033,"shares":13012033,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"09-16 11:50:56 EDT","open":24.9961,"high":24.9961,"low":24.9961,"amount":300.595392,"amplitude":0,"askPrice":25.16,"askSize":1000,"bidPrice":25.08,"bidSize":1000,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":24.9961,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":25,"preClose":24.9961,"latestTime":"16:10 EDT","volume":6,"amount":149.9766,"timestamp":1789503006975,"change":0.0039,"changeRate":0.000156,"amplitude":0},"volumeRatio":0.003578},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BGIA\",,,,,undefined,":{"symbol":"BGIA","floatShares":13012033,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.003578,"shares":13012033,"dividePrice":0,"high":24.9961,"amplitude":0,"preClose":24.9961,"low":24.9961,"week52Low":23.9707,"pbRate":"--","week52High":25.97,"institutionHeld":0,"latestPrice":24.9961,"eps":0,"divideRate":0,"volume":12,"delay":0,"ttmEps":0,"open":24.9961,"prevYearClose":25.2,"prevWeekClose":25.3728,"prevMonthClose":25.6781,"prevQuarterClose":24.4419,"fiveDayClose":25.4931,"twentyDayClose":25.1743,"sixtyDayClose":25.2046},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BGIA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BGIA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BGIA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BGIA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667978986","title":"諾和諾德攜手Anthropic，利用AI加速藥物研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667978986","media":"TradingKey中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667978986?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 21:21","pubTimestamp":1789564891,"startTime":"0","endTime":"0","summary":"TradingKey - 9月16日，诺和诺德（NVO）宣布与人工智能公司Anthropic达成合作，将利用Claude及相关AI模型支持药物研发，并进一步推进人工智能在科学研究和软件开发领域的应用。","market":"sh","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/analysis/stocks/us-stock/262170963-novo-nordisk-partners-anthropic-accelerate-drug-discovery-using-ai-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHAT","VTHR","BGIA","AIPO","QTOC","AGIX","IBBJ","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983620","title":"美股異動丨諾和諾德盤前升逾1% 將與Anthropic合作推進藥物研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983620","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983620?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:24","pubTimestamp":1789561486,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667983187","title":"諾和諾德與Anthropic將合作使用Claude推進藥物研發","url":"https://stock-news.laohu8.com/highlight/detail?id=2667983187","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667983187?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:15","pubTimestamp":1789560905,"startTime":"0","endTime":"0","summary":"【诺和诺德与Anthropic将合作使用Claude推进药物研发】据诺和诺德官网消息，诺和诺德与Anthropic将合作推进药物研发，诺和诺德将使用Claude辅助研发工作流程。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609163876227697.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609163876227697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IBBJ","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988768","title":"諾和諾德與Anthropic將合作推進藥物研發，諾和諾德將使用Claude輔助研發工作流程。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988768","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988768?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:08","pubTimestamp":1789560535,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988257","title":"諾和諾德(NVO.US)盤前拉升升逾1%，公司將與Anthropic合作推進藥物研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988257","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988257?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:01","pubTimestamp":1789560102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667102988","title":"諾和諾德將使用Claude Science開展研發工作流。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667102988","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667102988?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:00","pubTimestamp":1789560053,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988109","title":"諾和諾德與Anthropic開展合作，藉助Claude推進藥物研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988109","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988109?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:00","pubTimestamp":1789560027,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667988100","title":"市場消息：諾和諾德(NVO.US)與Anthropic將合作推進藥物研發。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667988100","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667988100?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:00","pubTimestamp":1789560026,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667406476","title":"諾和諾德(NVO.US)首席執行官：諾和諾德需要擴大其業務範圍以應對未來挑戰。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667406476","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667406476?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 21:23","pubTimestamp":1789478634,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667618217","title":"美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2667618217","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667618217?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 11:02","pubTimestamp":1789441373,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来周一表示，其口服减肥药Foundayo已在美国口服肥胖症治疗市场的新增患者中占据超过30%的份额，缩小了丹麦竞争对手诺和诺德凭借其Wegovy口服片剂所取得的早期领先优势。据了解，礼来的口服减肥药Foundayo于4月初上市，比诺和诺德的竞品Wegovy口服片晚了约三个月。诺和诺德在1月表示，预计到2030年，口服药物将占GLP-1减肥治疗使用量的三分之一以上。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1496046.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["THNR","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667249618","title":"美國口服減肥藥競爭升級！禮來(LLY.US)Foundayo搶下三成新患者，諾和諾德(NVO.US)先發優勢收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2667249618","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667249618?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 11:02","pubTimestamp":1789441373,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["THNR","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667966697","title":"台積電德國廠封頂，廠房主體工程完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2667966697","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667966697?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 09:31","pubTimestamp":1789435901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2250418816.HKD","MEMX","EMM","AVSE","CORO","FLTW","LU0384037296.USD","TEK","CGGO","STSM","ADVE","LU2237443978.SGD","CGNG","CHPX","FDTX","TSMU","EWT","AVXC","AIQ","SPTE","TSMG","EMXC","TSMX","TSMY","BLOX","KNOW","03145","SMH","EDZ","TSMZ","BGIA","EMC","TWSC","LU2237443622.USD","ESIM","AVEM","SPWO","CGIC","TINS","ASIA","BAI","TWN","TTEQ","WUGI","CWI","CGDG","CNEQ","IEMG","TSM","UMMA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667697348","title":"時序進入第三季下旬，台積電3nm、2nm先進製程與CoWoS先進封裝產能持續供不應求。供應鏈人士透露，英偉達、蘋果等持續","url":"https://stock-news.laohu8.com/highlight/detail?id=2667697348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667697348?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 09:21","pubTimestamp":1789435287,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AMDL","TSMU","THMR","EMXC","TSEU","UMCX","KSTR","TSMG","VGT","AMKX","ASIA","NVDL","AMUU","INTW","SEMY","TSMX","HBMX","TSMZ","AMKL","TWN","NVDA","2NVD.UK","AMDC","XSEM","AAPL","SEMI","ASMZ","TSM","CHPX","AMDG","NVDB","TWSC","FLTW","TMYY","IEMG","NVDS","CWI","ABFL","EWT","LRCC","TSMY","AMAU","EUVX","ASMG","BGIA","TCAI","DRMP","SHOC","EDZ","BESIY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131866623","title":"美股開盤 | 三大股指集體低開！半導體板塊普跌，邁威爾科技、ARM跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1131866623","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131866623?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 21:30","pubTimestamp":1789392630,"startTime":"0","endTime":"0","summary":"9月14日，美股三大股指集体低开，道琼斯指数跌0.24%，标普500指数跌0.71%，纳斯达克综合指数跌1.20%。半导体板块普跌，迈威尔科技、ARM跌超7%，英特尔、阿斯麦跌超6%，积电、博通跌超3%；The Elmet Group涨超32%，获战争部4.5亿美元投资承诺+20亿美元国防大单。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2211814178.USD","LU2210149790.SGD","LU0545039389.USD","LU0225283273.USD","NJUL","PMSE","ARTY","CHPS","LU1303367103.USD","ARMU","RSDE","IE0004445015.USD","FDTX","DECP","BK4575","LU0320765646.SGD","LU1935043536.SGD","LU0541502299.USD","LU2357627491.SGD","LU0203347892.USD","SG9999001424.SGD","IE00BJTD4N35.SGD","LU1037948541.HKD","OCTP","SG9999015986.USD","LU2265009873.SGD","IE00B3S45H60.SGD","LU1923622614.USD","LU2999663052.SGD","DIA","LU0942090050.USD","DXD","LU2213496289.HKD","SOXW","LU0672654240.SGD","LU0868494617.USD","IE00BK4W5M84.HKD","MARW","LU0795875086.SGD","SDS","LU0109392836.USD","LU2237443622.USD","LU1548497426.USD","FAI","JNEU","LU0308772762.SGD","PBFB","BK4585","EMXC","SG9999015952.SGD","LU0345768740.USD","SG9999000418.SGD","LU1868837136.USD","QDEC","USD","LU0985320562.USD","CGBL","LU1064131342.USD","LU2092937221.SGD","HK0000304805.HKD","MBCC","07568","LU2491049909.HKD","LU0094547139.USD","IE00BJJMRX11.SGD","XTOC","LU2089283258.USD","LU1066051225.USD","LU1670710661.SGD","NJAN","IE00BFXG0V08.USD","LU0912757837.SGD","SAVGOmain","LU1935043023.USD","LU2360106780.USD","UDOW","IE00BJLML261.HKD","LU1732799900.SGD","LU2860962120.EUR","03086","IE00B1BXHZ80.USD","PMMR","TSM","TWSC","STSM","LU2237957811.SGD","LU2065169927.USD","LU1145028129.USD","AVXC","BK4551","IE00BWXC8680.SGD","LU0048584097.USD","GSID","LU0795875169.SGD","LU1242518931.SGD","SG9999004220.SGD","AVGG","LU0158827948.USD","JULP","LU2023250504.SGD","TOPC","LU2506951792.HKD","LU0251132253.USD","LU2286300806.USD","SPRX","LU2244417387.USD","LU2357305700.SGD","LU1066051811.HKD","EMC","ARMA","LU0097036916.USD","LU0957808578.USD","IE00B42XCP33.USD","BK4579","AAUA","LU2750360997.AUD","JUNP","AVGW","LU0215105999.USD","LU1974910355.USD","LU0266013472.USD","ILOW","LU0784385840.USD","LU0345774631.USD","IE00B894F039.SGD","QQQA","AVGU","LU1267930730.SGD","XYLE","09086","IE00BKDWB100.SGD","FEBT","BK4581","BK4605","LU0056508442.USD","LU0979878070.USD","IE00BKPKM429.USD","LU0957791311.USD","LU2322448957.HKD","LU0788109477.HKD","LU0965508806.USD","LU1992135472.HKD","LU2473716301.USD","EWT","GSPY","LU0210536198.USD","LU1989764748.USD","QQQ","LU2054465674.USD","LU1734074674.USD","CGGO","LU2463028550.USD","LU1868837565.USD","LU2746668461.USD","IXN","LU0724617625.USD","LU0143863198.USD","LU0006306889.USD","LU2242650005.HKD","03145","LU0198837287.USD","LU2357125470.USD","SCHD","LU2098885051.SGD","IE00BDGV0183.EUR","LU0708995401.HKD","LU2279689827.SGD","IEFA","IE00BN8TJ469.HKD","IE00BLSP4452.SGD","LU0143863784.USD","LU2023251221.USD","LU2462591277.SGD","LU1803068623.USD","BK4598","BK4588","LU0072462343.USD","LU1670628061.USD","03165","ESLG","BK4602","LU0310799852.SGD","LU2250418816.HKD","IE0000B7K699.USD","ASMH","IE000WAW04H5.SGD","OEX","GJUL","LU2168564495.EUR","MMAX","LU2236285917.USD","LU2543165471.USD","DFUS","SMHX","LU0949170772.SGD","CPSD","LU0511384066.AUD","LU1244550494.USD","LU0096364046.USD","LU1153585028.USD","SMH","LU2083900584.USD","HK0000304797.USD","LU1366192091.USD","IE0004445239.USD","BK4609","LU0323239441.USD","LU1979441026.SGD","LU1551013425.SGD","LU0128525929.USD","LU1235294995.USD","LU2505996509.AUD","LU2756315664.SGD","LU2637965513.SGD","IE00B3M56506.USD","LEGR","FLTW","HK0000532082.HKD","IE000SO60NU8.SGD","DDM","LU1400636574.HKD","MAYM","IE00BZ199S13.USD","LU1804176565.USD","SEPP","LU0345769631.USD","LU0882747503.HKD","LU2237443978.SGD","CHAT","LU0079474960.USD","LU0289961442.SGD","BK4554","LU0661504455.SGD","LU1623119135.USD","LU1935042215.USD","EFA","LU2065171402.SGD","SPUU","ARLU","IE00BVYPNP33.GBP","LU0472753341.HKD","IE00B1XK9C88.USD","IE00B5TLWC47.USD","LU0823421416.USD","BK4593","LU0211328371.USD","LU0784385170.HKD","LU2491050071.SGD","LU2249611893.SGD","SPXU","LU1989772923.USD","IE00BMCWC346.EUR","LU1202635105.USD","LU2298321311.HKD","AIPI","INTW","IE00B775SV38.USD","LU1670711040.USD","AVGO","LU2290526834.HKD","SSO","LU0726765562.USD","CGNG","LU0965509101.SGD","AVGC","NAPR","IVV","TDIV","EMM","MYMmain","BK4147","LU0784384876.USD","TQQY","IE00B19Z9P08.USD","LU2271345857.HKD","LU0061474705.USD","CJUL","IE00BFSS7M15.SGD","LU0321505868.SGD","LU0109391861.USD","TSMU","LU1066053197.SGD","DLNV","LU2247934214.USD","IE00BKVL7J92.USD","LU0157215616.USD","TEK","LU2430703178.SGD","LU1069344957.HKD","IE00BMPRXR70.SGD","IE00BVYPNW00.USD","LU0476273544.USD","CNEQ","LU0345770308.USD","LU1037948897.HKD","IE00B5949003.HKD","PBJN","SG9999004303.SGD","LU0742534661.SGD","BK4503","IE0001KFT4U8.USD","LU1244550221.USD","LU1267930490.SGD","CIBR","LU2461242641.AUD","HIBL","LU2360032135.SGD","QQQX","IE00BK4W5L77.USD","JGRO","LU2361044949.HKD","BK4504","MRVU","LU0133085943.USD","NVDK","LU0689472784.USD","LU1127390331.HKD","RSST","IE00BYV24P56.USD","SPYU","IE0034235188.USD","LU0061474960.USD","SQQQ","LU1282649067.USD","VGT","LU2764263039.SGD","LU0786609619.USD","LU1645745479.HKD","LU0787776722.HKD","LU1814569148.SGD","LU2065171311.SGD","LU2360108059.USD","LU2347655073.USD","IE00B775H168.HKD","IE00BVYPNV92.GBP","LU0082616367.USD","LU0174119429.USD","BK4526","LU0080751232.USD","FENI","LU0127658192.USD","ADVE","JANU","PQNT","LU0203202063.USD","ARM","LU0417517546.SGD","FFGX","INTC","LU0234570918.USD","SPWO","LU0466842654.USD",".DJI","IE00BMPRXN33.USD","BK4532","TTXD","PMJN","IE00B4JS1V06.HKD","OEF","LU0256863902.USD","CPSO","LU1868836914.USD","LU2491050154.USD","OCTT","LU1670711123.USD","LU0868494708.USD","LU1823568750.SGD","LU0175139822.USD","LU2403377893.USD","LU0149725797.USD","SEPM","AIFD","LU1670756490.USD","LU0289739343.SGD","LU1935043452.HKD","LU2720916845.USD","LU0203345920.USD","LU2272731600.USD","LU0823434740.USD","LU2458330243.SGD","LU2471134879.HKD","IE0009356076.USD","LU2750360641.GBP","LU2168564149.EUR","DRIV","MESmain","LU0708994859.HKD","LU0359201612.USD","SDOW","LU0354030438.USD","LU1934455863.HKD","LU1868837300.USD","LU0642271901.SGD","LU2168563687.JPY","LU1023057109.AUD","SPTE","KNOW","JUNT","ASIA","LU0541501648.USD","LU0072462426.USD","DBEF","SPYM","MAYP","ASMG","IE000BZT7R73.USD","LU2322448791.USD","TQQQ","07266","LU2168564222.USD","AVSE","LU2237438978.USD","LU2237957902.USD","LU0124676726.USD","SINTCmain","ARMG","LU2237443382.USD","EPAI","LINT","LU2361044865.SGD","NOCT","LU2106854487.HKD","LU2111349929.HKD","BK4533","LU0965509010.AUD","IE000F7OJYX1.SGD","ESIM","LU2471134952.CNY","LU0316494557.USD","LU1242518857.USD","DJAN","LU2272731782.SGD","LU0057025933.USD","BBUS","LU0321505439.SGD","LU0640476718.USD","LU2065170008.USD","LU2487616109.SGD","IE00BLSP4239.USD","LU0553294199.USD","IETC","BK4550","LU2347655156.SGD","SPY","LU0889565833.HKD","FLJJ","TTXU","YMmain","LU0251142724.SGD","DJUL","IE00BVYPNQ40.USD","LU1267930573.SGD","LU2361045086.USD","LU0143551892.USD","ESmain","LU1048588211.SGD","LU1211504680.USD","LU1732800096.USD","XNTK","LU1868838027.USD","LU2462591350.SGD","TRFK","LU1868837722.USD","AUGU","LU1244550577.SGD","LU0070217475.USD","LU0943347566.SGD","SH","09834","LU2746668974.SGD","LU1084165304.USD","LU2592432038.USD","LU1989772840.SGD","LU0488056044.USD","LU2954938101.SGD","ELMT","JANP","LU0256863811.USD","LU0353189763.USD","HBMX","FXL","TWN","03034","ASML","IE00BHPRN162.USD","LU0345770993.USD","07522","LU0276348264.USD","LU2764263203.CNY","SCHK","LU1551013342.USD","QID","LU0323240290.USD","LU0792757196.USD","LU1934455277.USD","03455","LU1988902786.USD","LU1035775433.USD","LU0965509283.SGD","BK4591","HAKY","LU2125909593.SGD","ARMW","BK4512","LU2355687059.USD","TINS","UXAP","LU0354030511.USD","LU2023250330.USD",".IXIC","IE00BJJMRY28.SGD","LU0158827781.USD","LU0823414551.USD","CHPX","LU1989764664.SGD","SIXZ","LU0345769128.USD","LU2471134796.USD","LU0048573561.USD","LU0859254822.USD","APRP","GPIX","IE00BGHQF631.EUR","SG9999003800.SGD","LU1316542783.SGD","BK4566","LU1868836757.USD","07261","TSMX","IE0004086264.USD","ONEQ","LU0353189680.USD","BK4543","LU1923623000.USD","LU1720051108.HKD","UPRO","LU0210533765.USD","LU0572940350.SGD","SPYQ","FB","LU2095319765.USD","LU0878005551.USD","DAUG","IFLR","LU0210528500.USD","PQV","BK4612","INT","LU0264606111.USD","APOC","AIQ","LU0203201768.USD","LU0738911758.USD","MRVL","USXF","LU1852331112.SGD","LU2148611432.USD","LU2168564065.EUR","LU1301847155.USD","LU0823421333.USD","SSS","IE00BZ9MQY76.HKD","LU2458330169.SGD","IE0005OL40V9.USD","IE000MB6IJN5.SGD","LU0784383803.USD","LU1366333091.USD","LU1951200564.SGD","LU0683600562.USD","GAUG","SPYI","FTXL","LU0719512351.SGD","THMR","IE00BZ1G4Q59.USD","LU2210150020.SGD","LU2125154778.USD","SPDN","BK4527","XLK","LU0345768153.USD","LU1119994496.HKD","LU2089284900.SGD","LU2602419157.SGD","UMMA","LU1992135399.USD","LU0061475181.USD","LU0154236417.USD","LU0310800379.SGD","LU1720051017.SGD","PQX","BK4141","LU2272731865.HKD","SPYH","IE00BQXX3F31.USD","LU0889566641.SGD","SG9999015945.SGD","SOXY","LU1815336760.USD","SMAX","YSPY","TWOX","LU0572939691.SGD","SOXX","LU1868836591.USD","DBEU","LU0096362180.USD","AVEM","LU1861215975.USD","LU1674673428.USD","LU1712237335.SGD","SHLD","LU0444971666.USD","LU0314104364.USD","GTEK","LU0384037296.USD","LU2041044095.USD","IE00BQXX3C00.GBP","LU0106261372.USD","LU2125154935.USD","LU2430703095.HKD","LU2764262908.HKD","PSQ","SG9999002232.USD","ASMZ","CWI","LU1400636657.SGD","LU1670627923.USD","DMAX","LU2023250843.SGD","AVGX","AIS","LU2237443895.HKD","LU1066051498.USD","MRVX","IE00B7KXQ091.USD","SG9999001440.SGD","LU1280957306.USD","LU2242649171.HKD","LU0238689110.USD","LU1508157978.USD","BK4505","HK0000914660.USD","LU0053666078.USD","LU2471134523.USD","IE00BMPRXQ63.HKD","SG9999002224.SGD","LU1914381329.SGD","LU2430703251.USD","QLD","IE0034235303.USD","DOG","LU0964807845.USD","AOCT","LU2211815571.USD","LU2663582299.SGD","IE00BJTD4V19.USD","LU0234572021.USD","LU1674673691.USD","LU1934455194.USD","LU2237443465.HKD","SGXZ99366536.SGD","SPXS","LU1778281490.HKD","LU2028103732.USD","TSMG","WUGI","IE00B3PB1722.GBP","LU0170899867.USD","LU2063271972.USD","LU2456880835.USD","PFEB","LU2433249047.HKD","LU1691799644.USD","02834","LU1046421795.USD","LU0820561818.USD","LU1861220033.SGD","LU1400636491.USD","TTEQ","PBNV","BK4604","LU0187121727.USD","LU0251131958.USD","AVL","LU0323591593.USD","LU2108987350.USD","LU2294711713.HKD","BK4515","DTCR","LU0211327993.USD","IE00BQXX3D17.EUR","LU0820561909.HKD","LU1629891620.HKD","IE00B19Z9Z06.USD","LU2505996681.GBP","LU0011850046.USD","LU2133065610.SGD","LU1935042488.USD","GPIQ","IE0004091025.USD","LU1261432733.SGD","USPX","IE00BFSS8Q28.SGD","BK4559","SOXQ","LU0069063385.USD","LU2931357623.SGD","LU0878004406.USD","LU0949170426.SGD","LU2896262040.SGD","LU0320765059.SGD","LU1815333072.USD","BK4548","SHOC","CORO","LU0289960550.SGD","LU1951198990.SGD","LU1282649810.SGD","FTEC","LU2264538146.SGD","LU2417539215.USD","SGXZ23171101.USD","VOO","LU2087625088.SGD","INYY","LU0084288322.USD","BAI","LU0689626769.HKD","IE00BYQQ9H92.USD","QMAR","PBMY","LU1917777945.USD","LU0359201885.HKD","LU2462157665.USD","AUGZ","NULC","SG9999015978.USD","IE00BBT3K403.USD","SG9999011175.SGD","IE000M9KFDE8.USD","LU1169590202.USD","LU0823414478.USD","LU2125909247.SGD","LU2756315318.SGD","SGXZ51526630.SGD","LU1935042991.SGD","DJUN","BK4534","AVS","CGIC","SPXL","LU1232071149.USD","XDIV","MEMX","SPYB","LU0820562030.AUD","ASMU","IEMG","BK4535","PMNV","CPSM","CNAV","LU0359202008.SGD","LU1718418525.SGD","LU2237443549.SGD","LU2360107168.USD","LU2420271590.USD","BK4529","CGDG","EDZ","IE00BGHQDM52.EUR","BLOX","HK0000914686.HKD","LU2089985449.USD","LU0823434583.USD","TSMY","LU1003077747.HKD","QQQM","LU0345774391.USD","LU1169589451.USD","IE00BD6J9T35.USD","LU1267930813.SGD","LU0861579265.USD","LU1642822529.SGD","LU0274383776.USD","SGXZ81514606.USD","IE00BN29S564.USD","MVLL","LU0029864427.USD","LU1162221912.USD",".SPX","BGIA","LU1803068979.SGD","LU1323610961.USD","LU0348723411.USD","LU0081259029.USD","LU0444973449.USD","LU1670710588.SGD","TSMZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667914669","title":"諾和諾德公司開啓股份回購計劃。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667914669","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667914669?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 21:14","pubTimestamp":1789391666,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["AAPY","IOSX","APLY","AAPW","AAPE","BGIA","AAPX","AAPB","AAPD","AAPU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667663485","title":"諾和諾德(NVO.US)更名「Novo」煥新出發 多線突圍能否驅散股價陰霾？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667663485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667663485?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:44","pubTimestamp":1789386265,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，丹麦药企诺和诺德推出以更短名称“Novo”为核心的全面品牌重塑。诺和诺德已通过下调现金价格、扩大直销以及重新聚焦肥胖症、糖尿病及相关心血管代谢疾病予以回应。与此同时，诺和诺德下一代注射剂CagriSema在近期对比中再次落后于礼来的Zepbound。此外，诺和诺德决定停止两项涉及实验性心血管药物Ziltivekimab的试验，原因是“展示有意义益处的可能性低”。2026年8月27日，中国国家药品监督管理局正式受理诺和诺德口服版Wegovy的上市申请。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667266348","title":"諾和諾德(NVO.US)更名「Novo」煥新出發 多線突圍能否驅散股價陰霾？","url":"https://stock-news.laohu8.com/highlight/detail?id=2667266348","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667266348?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 19:44","pubTimestamp":1789386265,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667651989","title":"諾和諾德更名為「諾和（Novo）」，全力爭奪減肥藥市場份額","url":"https://stock-news.laohu8.com/highlight/detail?id=2667651989","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667651989?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 16:52","pubTimestamp":1789375920,"startTime":"0","endTime":"0","summary":"诺和公布了全新经营准则，核心是确立清晰工作重点、简化业务流程，以此实现业务聚焦，提升运转效率。诺和诺德于周一宣布，将对外品牌更名为 “Novo（诺和）” 并更新企业文化，全力争取减肥药领域的市场份额。诺和将于 9 月 21 日资本市场日活动上，详细披露业务战略调整方案。根据礼来财报演示文稿引用的艾昆纬数据，第二季度减肥药市场，诺和市场份额仅 38.8%，落后于礼来的 60.9%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-09-14/doc-inirutnu9457800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["APXH","BGIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667530016","title":"諾和諾德(NVO.US)：公司將品牌名稱更新為「Novo」，並調整企業文化。此舉是為了幫助公司重新奪回減肥藥市場份額。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667530016","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667530016?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:15","pubTimestamp":1789370127,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BGIA","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653024","title":"歐洲科技股普遍走低 阿斯麥下跌4.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653024","media":"东方财富Choice...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653024?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 15:10","pubTimestamp":1789369843,"startTime":"0","endTime":"0","summary":"欧洲科技股普遍走低，阿斯麦下跌4.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873376216.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873376216.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["JIG","PQNT","SPWO","BGIA","PJIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":1,"totalSize":122,"code":"91000000","status":"200"}]}}